E27.5
Adrenomedullary hyperfunction
Clinical Classification Guidelines
Inclusion Terms
- Adrenomedullary hyperplasia
- Catecholamine hypersecretion
Code Also
- , if applicable:
- malignant pheochromocytoma (C74.1-)
- pheochromocytoma (benign) (D35.0-)
- secondary hypertension (I15.2)
Medical Intelligence & Overview
Adrenomedullary hyperfunction is a condition characterized by the excessive activity of the adrenal medulla, the inner part of your adrenal glands located above your kidneys. This overactivity often results in an increased production and release of catecholamines, hormones such as adrenaline and noradrenaline. These hormones play vital roles in the body's 'fight or flight' response, but when produced in excess, they can lead to various health symptoms and complications. The condition is classified under ICD-10 code E27.5 and is sometimes related to or caused by adrenomedullary hyperplasia, an enlargement of the adrenal medulla due to increased cell growth.
Causes & Symptoms
Clinical Causes: Adrenomedullary hyperplasia, which involves increased cell growth in the adrenal medulla Tumors of the adrenal medulla, such as pheochromocytomas Genetic factors that influence hormone production Certain inherited syndromes that predispose to adrenal gland tumors or hyperfunction
Key Symptoms: High blood pressure (hypertension) Rapid heartbeat (tachycardia) Sweating excessively Headaches Nervousness or anxiety Pale skin, sometimes with flushing Weakness or fatigue Weight loss without a clear reason
Diagnostic & Treatment
Diagnosis Path: Diagnosing adrenomedullary hyperfunction involves a combination of approaches. Doctors typically start with a review of your symptoms and medical history, followed by physical examinations. Laboratory tests are critical and include measurement of catecholamines and their metabolites in blood and urine samples. Imaging studies such as CT scans or MRIs of the adrenal glands help identify any enlargement or tumors. In some cases, specialized tests like adrenal vein sampling may be performed to confirm the diagnosis and localize hyperactivity.
Treatment Protocols: Treatment strategies are aimed at controlling hormone levels and addressing the underlying causes. Medications such as alpha-blockers and beta-blockers are used to manage symptoms like high blood pressure and rapid heartbeat. Surgical removal of problematic adrenal tissue or tumors might be necessary if a tumor is identified. In cases of hyperplasia without tumors, medication management and regular monitoring are often recommended. It's essential to work closely with healthcare providers to develop a personalized treatment plan and monitor your condition over time.
Clinical Advice & FAQs
Billing Guidance
Is E27.5 a billable ICD-10 code?
Yes, E27.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E27.5?
Clinical documentation must specify the nature of Adrenomedullary hyperfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference